Therapeutic application of melatonin in mild cognitive impairment
Abstract: Mild cognitive impairment (MCI) is an etiologically heterogeneous syndrome defined by cognitive impairment in advance of dementia. We previously reported in a retrospective analysis that daily 3 - 9 mg of a fast-release melatonin preparation given p. o. at bedtime for up to 3 years signifi...
Guardado en:
| Autores principales: | Cardinali, Daniel Pedro, Vigo, Daniel Eduardo, Olivar, Natividad, Vidal, María Florencia, Furio, Analía M., Brusco, Luis I. |
|---|---|
| Formato: | Artículo |
| Lenguaje: | Inglés Inglés |
| Publicado: |
e-Century Publishing
2019
|
| Materias: | |
| Acceso en línea: | https://repositorio.uca.edu.ar/handle/123456789/1608 |
| Aporte de: |
Ejemplares similares
-
An exploratory study of sleep-wake differences of autonomic activity in patients with mild cognitive impairment : the role of melatonin as a modulating factor
por: Abulafia, Carolina Andrea, et al.
Publicado: (2023) -
Melatonin therapy in patients with Alzheimer's disease
por: Cardinali, Daniel Pedro, et al.
Publicado: (2019) -
Heart rate variability and mild cognitive impairment in parkinson’s disease
por: Merello, Marcelo, et al.
Publicado: (2020) -
Melatonin and Benzodiazepine / Z Drug Abuse
por: Cardinali, Daniel Pedro, et al.
Publicado: (2020) -
Melatonin signaling as a link between sleep and circadian biology : practical implications
por: Cardinali, Daniel Pedro, et al.
Publicado: (2020)